Futura Medical plc (LON:FUM – Get Free Report) shares traded down 14.3% on Friday . The company traded as low as GBX 12.14 ($0.15) and last traded at GBX 12.24 ($0.16). 631,683 shares changed hands during trading, a decline of 26% from the average session volume of 854,730 shares. The stock had previously closed at GBX 14.29 ($0.18).
Futura Medical Stock Down 9.0 %
The business’s 50-day moving average is GBX 26.15 and its two-hundred day moving average is GBX 31.91. The company has a market capitalization of £40.55 million, a P/E ratio of -10.73 and a beta of 1.25.
Futura Medical Company Profile
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel.
Further Reading
- Five stocks we like better than Futura Medical
- Insider Trades May Not Tell You What You Think
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Do ETFs Pay Dividends? What You Need to Know
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Comparing and Trading High PE Ratio Stocks
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.